DEFICIENT MISMATCH REPAIR COLON CANCER

Clinical trials for DEFICIENT MISMATCH REPAIR COLON CANCER explained in plain language.

Never miss a new study

Get alerted when new DEFICIENT MISMATCH REPAIR COLON CANCER trials appear

Sign up with your email to follow new studies for DEFICIENT MISMATCH REPAIR COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Could immunotherapy spare some colon cancer patients from surgery?

Disease control Not yet recruiting

This study tests giving an immunotherapy drug (pembrolizumab) before surgery to people with a specific type of colon cancer (dMMR). The goal is to see if the drug can shrink or eliminate the tumor so some patients may avoid surgery and instead be closely monitored. About 152 adul…

Matched conditions: DEFICIENT MISMATCH REPAIR COLON CANCER

Phase: PHASE2 • Sponsor: Ismail Gögenur • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC

DEFICIENT MISMATCH REPAIR COLON CANCER

Get alerted when new DEFICIENT MISMATCH REPAIR COLON CANCER trials appear

Could immunotherapy spare some colon cancer patients from surgery?